Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Receivables - Net (2018 - 2021)

Historic Receivables - Net for Q32 Bio (QTTB) over the last 4 years, with Q3 2021 value amounting to $100000.0.

  • Q32 Bio's Receivables - Net fell 7500.0% to $100000.0 in Q3 2021 from the same period last year, while for Sep 2021 it was $100000.0, marking a year-over-year decrease of 7500.0%. This contributed to the annual value of $400000.0 for FY2020, which is 0.0% changed from last year.
  • Q32 Bio's Receivables - Net amounted to $100000.0 in Q3 2021, which was down 7500.0% from $200000.0 recorded in Q2 2021.
  • Q32 Bio's Receivables - Net's 5-year high stood at $800000.0 during Q4 2018, with a 5-year trough of $100000.0 in Q3 2021.
  • For the 4-year period, Q32 Bio's Receivables - Net averaged around $350000.0, with its median value being $350000.0 (2019).
  • Its Receivables - Net has fluctuated over the past 5 years, first surged by 10000.0% in 2020, then plummeted by 7500.0% in 2021.
  • Q32 Bio's Receivables - Net (Quarter) stood at $800000.0 in 2018, then tumbled by 50.0% to $400000.0 in 2019, then changed by 0.0% to $400000.0 in 2020, then crashed by 75.0% to $100000.0 in 2021.
  • Its Receivables - Net stands at $100000.0 for Q3 2021, versus $200000.0 for Q2 2021 and $300000.0 for Q1 2021.